Effects of Germanium Biotite Supplement on Immune Responses of Vaccinated Mini-pigs to Foot-and-Mouth Disease Virus Challenge

References

• Aikoh T, Tomokuni A, Matsukii T, et al. (1998). Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro. Int J Oncol, 12, 1355–9
   Google Scholar
• Albina JE, Abate JA, Henry Jr WL. (1991). Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J Immunol, 147, 144–8
   PubMed Web of Science ®Google Scholar
• Barnett PV, Cox SJ, Aggarwal N, et al. (2002). Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. Vaccine, 20, 3197–208
   PubMed Web of Science ®Google Scholar
• Biron CA. (1999). Initial and innate responses to viral infections—pattern setting in immunity or disease. Curr Opin Microbiol, 2, 374–81
   PubMed Web of Science ®Google Scholar
• Cox SJ, Aggarwal N, Statham RJ, Barnett PV. (2003). Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine, 21, 1336–47
   PubMed Web of Science ®Google Scholar
• Cox SJ, Barnett PV. (2009). Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: A review. Vet Res, 40, 13–42
   Google Scholar
• de Leeuw PW, Tiessink JWA, Frenkel S, van Bekkum JG. (1979a). Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D). Zbl Vet Med B, 26, 85–97
   Google Scholar
• de Leeuw PW, Tiessink JWA, van Bekkum JG. (1979b). The challenge of vaccinated pigs with foo-and-mouth disease virus. Zbl Vet Med B, 26, 98–109
   Google Scholar
• Deshmane SL, Kremlev S, Amini S, Sawaya BE. (2009). Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res, 29, 313–26
   PubMed Web of Science ®Google Scholar
• Eblé PL, Bouma A, de Bruin MGM, et al. (2004). Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. Vaccine, 22, 1372–8
   Google Scholar
• Elnekave E, Li Y, Zamir L, et al. (2013). The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease. Vaccine, 31, 879–85
   Google Scholar
• Golde WT, Pacheco JM, Duque H, et al. (2005). Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine, 23, 5775–82
   PubMedGoogle Scholar
• Handel TM, Domaille PJ. (1996). Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry, 35, 6569–84
   PubMed Web of Science ®Google Scholar
• Holian A, Uthman MO, Goltsova T, et al. (1997). Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environ Health Perspect, 105, 1139–42
   PubMed Web of Science ®Google Scholar
• Hu K, He X, Yu F, et al. (2011). Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis. Immunol Invest, 40, 265–78
   PubMed Web of Science ®Google Scholar
• Inn KS, Lee GJ, Quan FS. (2013). A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice. Immunol Invest, 43, 236–54
   Google Scholar
• Jung BG, Lee JA, Lee BJ. (2013). Antiviral effect of dietary germanium biotite supplementation in pigs experimentally infected with porcine reproductive and respiratory syndrome virus. J Vet Sci, 14, 135–41
   Google Scholar
• Jung BG, Toan NT, Cho SJ, et al. (2010). Dietary aluminosilicate supplement enhances immune activity in mice and reinforces clearance of porcine circovirus type 2 in experimentally infected pigs. Vet Microbiol, 143, 117–25
   Google Scholar
• Jung M, Jung BG, Cha SB, et al. (2012). The effects of germanium biotite supplement as a prophylactic agent against respiratory infection in calves. Pak Vet J, 32, 319–24
   Google Scholar
• Li R, Sakwiwatkul K, Yutao L, Hu S. (2009). Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM). Vaccine, 27, 2094–8
   Google Scholar
• Maanen CV, Terpstra C. (1989). Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J Immunol Methods, 124, 111–19
   Google Scholar
• Martinez FO, Helming L, Gordon S. (2009). Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol, 27, 451–83
   PubMed Web of Science ®Google Scholar
• McCullough KC, Bruckner L, Schaffner R, et al. (1992). Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet Microbiol, 30, 99–112
   PubMed Web of Science ®Google Scholar
• Mollick JA, Cook RG, Rich RR. (1989). Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science, 244, 817–20
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol, 8, 958–69
   PubMed Web of Science ®Google Scholar
• Orsel K, de Jong MCM, Bouma A, et al. (2007). Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs. Vaccine, 25, 6381–91
   PubMed Web of Science ®Google Scholar
• Parida S, Fleming L, Oh Y, et al. (2008). Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection. Vaccine, 26, 3469–79
   Web of Science ®Google Scholar
• Parida S, Oh Y, Reid SM, et al. (2006). Interferon-γ production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine, 24, 964–9
   PubMed Web of Science ®Google Scholar
• Park JH. (2013). Requirements for improved vaccines against foot-and-mouth disease epidemics. Clin Exp Vaccine, 2, 8–18
   PubMedGoogle Scholar
• Park JH, Lee KN, Ko YJ, et al. (2013). Control of foot-and-mouth disease during 2010–2011 epidemic, South Korea. Emerg Infect Dis, 19, 655–9
   Google Scholar
• Rodriguez-Fuentes G, Barrios M, Iraizoz A, et al. (1997). Enterex: Anti-diarrheic drug based on purified natural clinoptilolite. Zeolites, 19, 441–8
   Google Scholar
• Shieh JJ, Liang CM, Chen CY, et al. (2001). Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization. Vaccine, 19, 4002–10
   Google Scholar
• Summerfield A, Guzylack-Piriou L, Harwood L, McCullough KC. (2009). Innate immune responses against foot-and-mouth disease virus: Current understanding and future directions. Vet Immunol Immunopathol, 128, 205–10
   Google Scholar
• Swaney LM. (1988). A continuous bovine kidney cell line for routine assays of foot-and-mouth disease virus. Vet Microbiol, 18, 1–14
   Google Scholar
• Toledo JR, Barrera M, Farnós O, et al. (2010). Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs. Vaccine, 28, 7907–14
   Google Scholar
• Ueki A, Yamaguchi M, Ueki H, et al. (1994). Polyclonal human T-cell activation by silicate in vitro. Immunology, 82, 332–5
   PubMed Web of Science ®Google Scholar